- Home
- OCS vs NKTR Comparison
OCS vs NKTR Comparison
Compare OCS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- NKTR
- Stock Information
- Founded
- OCS 2003
- NKTR 1990
- Country
- OCS Switzerland
- NKTR United States
- Employees
- OCS N/A
- NKTR N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- OCS Health Care
- NKTR Health Care
- Exchange
- OCS Nasdaq
- NKTR Nasdaq
- Market Cap
- OCS 1.0B
- NKTR 1.2B
- IPO Year
- OCS N/A
- NKTR 1994
- Fundamental
- Price
- OCS $19.18
- NKTR $55.85
- Analyst Decision
- OCS Strong Buy
- NKTR Strong Buy
- Analyst Count
- OCS 4
- NKTR 5
- Target Price
- OCS $41.00
- NKTR $89.00
- AVG Volume (30 Days)
- OCS 99.7K
- NKTR 871.9K
- Earning Date
- OCS 11-06-2025
- NKTR 11-06-2025
- Dividend Yield
- OCS N/A
- NKTR N/A
- EPS Growth
- OCS N/A
- NKTR N/A
- EPS
- OCS N/A
- NKTR N/A
- Revenue
- OCS $960,668.00
- NKTR $62,600,000.00
- Revenue This Year
- OCS $32.89
- NKTR N/A
- Revenue Next Year
- OCS $1,043.16
- NKTR N/A
- P/E Ratio
- OCS N/A
- NKTR N/A
- Revenue Growth
- OCS N/A
- NKTR N/A
- 52 Week Low
- OCS $14.00
- NKTR $6.48
- 52 Week High
- OCS $23.08
- NKTR $66.92
- Technical
- Relative Strength Index (RSI)
- OCS 43.14
- NKTR 48.19
- Support Level
- OCS $19.00
- NKTR $53.60
- Resistance Level
- OCS $19.63
- NKTR $66.92
- Average True Range (ATR)
- OCS 0.74
- NKTR 3.93
- MACD
- OCS -0.35
- NKTR -1.20
- Stochastic Oscillator
- OCS 6.04
- NKTR 21.02
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.